Skip to main content

Advertisement

SpringerLink
Log in

Effect of allogeneic bone marrow–derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Primary biliary cirrhosis (PBC) is a slowly progressive autoimmune disease of unknown mechanism. We established a PBC animal model by injecting C57BL/6 mice with polyinosinic–polycytidylic acid sodium (polyI:C) to investigate the therapeutic effect of bone marrow–derived mesenchymal stem cells (BM-MSC) on this model. After 6 weeks of MSC infusion, serum aminotransferase and autoimmune antibodies declined, and histological examination by hematoxylin and eosin staining showed significant amelioration of monocytes infiltration around bile ducts of mice treated with BM-MSC. Interestingly, allogeneic BM-MSC transplantation markedly increased CD4+Foxp3+ regulatory T cells in peripheral blood as well as in lymph nodes when analyzed by flow cytometry. Further examination showed serum TGF-β1 increased but IFN-γ decreased significantly in PBC mice treated with MSC, while with no obvious change in IL-10 expression. Our results for the first time suggested that BM-MSC transplantation could regulate systemic immune response and enhance recovery in liver inflammation of PBC mice, raising the possibility for clinical application of allogeneic MSC in treatment of early-stage PBC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273

    Article  CAS  PubMed  Google Scholar 

  2. Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR, Dutch PBC Study Group (2009) Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136:1281–1287

    Article  CAS  PubMed  Google Scholar 

  3. Gong Y, Huang Z, Christensen E, Gluud C (2007) Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol 102:1799–1807

    Article  CAS  PubMed  Google Scholar 

  4. Prince M, Christensen E, Gluud C (2005) Glucocorticosteroids for primary biliary cirrhosis. Cochrane Database Syst Rev 2:CD003778

    PubMed  Google Scholar 

  5. Silveira MG, Lindor KD (2008) Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clin Liver Dis 12:425–443

    Article  PubMed  Google Scholar 

  6. Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I (2009) Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal. Transplant Proc 41:1707–1712

    Article  CAS  PubMed  Google Scholar 

  7. Saulnier N, Lattanzi W, Puglisi MA, Pani G, Barba M, Piscaglia AC, Giachelia M, Alfieri S, Neri G, Gasbarrini G, Gasbarrini A (2009) Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. Eur Rev Med Pharmacol Sci 13:71–78

    PubMed  Google Scholar 

  8. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389–397

    Article  CAS  PubMed  Google Scholar 

  9. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822

    Article  CAS  PubMed  Google Scholar 

  10. Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L (2008) Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 5:417–424

    Article  PubMed  Google Scholar 

  11. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421–1432

    Article  CAS  PubMed  Google Scholar 

  12. Beyer Nardi N, da Silva Meirelles L (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249–282

    PubMed  Google Scholar 

  13. Inamura K, Tsuji H, Nakamoto Y, Suzuki M, Kaneko S (2006) Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis. Clin Exp Immunol 145:93–100

    Article  CAS  PubMed  Google Scholar 

  14. Okada C, Akbar SM, Horiike N, Onji M (2005) Early development of primary biliary cirrhosis in female C57BL/6 mice because of polyI:C administration. Liver Int 25:595–603

    Article  CAS  PubMed  Google Scholar 

  15. Jiang T, Han Z, Chen S, Wu C, Tang Y, Qian C, Chen Y, Zhou Y, Zhu Y, Gu M, Zhu L, Yao D, Deng A, Zhong R (2009) Resistance to activation-induced cell death and elevated FLIPL expression of CD4+ T cells in a polyI:C-induced primary biliary cirrhosis mouse model. Clin Exp Med 9:269–276

    Article  CAS  PubMed  Google Scholar 

  16. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH, Hung SC, Fu YS (2009) The therapeutic potential of human umbilical mesenchymal stem cells from Wharton’s Jelly in the treatment of rat liver fibrosis. Liver transpl 15:484–495

    Article  PubMed  Google Scholar 

  17. Yan Y, Xu W, Qian H, Si Y, Zhu W, Cao H, Zhou H, Mao F (2009) Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int 29:356–365

    Article  CAS  PubMed  Google Scholar 

  18. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE 2:e941

    Article  PubMed  Google Scholar 

  19. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345–352

    Article  CAS  PubMed  Google Scholar 

  20. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, Chuang YH, Nakamura T, Saito S, Shimoda S, Tanaka A, Bowlus CL, Takano Y, Ansari AA, Coppel RL, Gershwin ME (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43:729–737

    Article  PubMed  Google Scholar 

  21. Sakaki M, Hiroishi K, Baba T, Ito T, Hirayama Y, Saito K, Tonoike T, Kushima M, Imawari M (2008) Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 38:354–361

    Article  CAS  PubMed  Google Scholar 

  22. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006–1019

    Article  PubMed  Google Scholar 

  23. Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399

    Article  CAS  PubMed  Google Scholar 

  24. Bommireddy R, Babcock GF, Singh RR, Doetschman T (2008) TGFβ1 deficiency does not affect the generation and maintenance of CD4+ CD25+ Foxp3+ putative Treg cells, but cause their numerical inadequacy and loss of regulatory function. Clin Immunol 127:206–213

    Article  CAS  PubMed  Google Scholar 

  25. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P (2010) Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 184:5885–5894

    Article  CAS  PubMed  Google Scholar 

  26. Li MO, Wan YY, Sanjabi S, Robertson AL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146

    Article  CAS  PubMed  Google Scholar 

  27. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML (2007) Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 363:247–252

    Article  CAS  PubMed  Google Scholar 

  28. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R (2007) Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10:459–466

    CAS  PubMed  Google Scholar 

  29. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, Soleimani M (2009) Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 21:1199–1205

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Jiangsu Province 135 Talent Foundation (RC2007004).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, 210008, Nanjing, Jiangsu, China

    Dandan Wang, Huayong Zhang, Jun Liang, Zhifeng Gu, Xiaolei Ma, Jing Huang, Jing Lin & Lingyun Sun

  2. Immunology Laboratory, Nanjing University Medical School, Nanjing, China

    Yayi Hou

  3. Department of Pathology and Center of Infection and Immunology, The University of Hong Kong, Hong Kong, China

    Liwei Lu

Authors
  1. Dandan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huayong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhifeng Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaolei Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yayi Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Liwei Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Lingyun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lingyun Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, D., Zhang, H., Liang, J. et al. Effect of allogeneic bone marrow–derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model. Clin Exp Med 11, 25–32 (2011). https://doi.org/10.1007/s10238-010-0105-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-010-0105-6

Keywords

Search

Navigation